From a clinical study standpoint, the development of novel treatments requires a rigorous and detailed approach. We are witnessing a pivotal shift from traditional models, embracing tailored medicine and increasingly complex methodologies. Novel biomarker discovery, coupled with sophisticated imaging techniques, is allowing for a far more precise a